INGENUS

DOCETAXEL

Manufacturer:

INGENUS

Docetaxel HCPCS:

J9172

HCPCS Code Descriptor:

Injection, docetaxel (ingenus) not therapeutically equivalent to j9171, 1 mg

Category:

J Code

Docetaxel NDCs:

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Docetaxel:

DOCETAXEL is a Oncology drug manufactured by INGENUS and administered via the route of administration. The J Code: J9172 is aligned to the drug DOCETAXEL.

ACCESS PRICING AND MORE BY REGISTERING

J9172 Added Date:

January 1, 2024

J9172 Effective Date:

January 1, 2024

J9172 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Docetaxel billing and coding information.
Our team did not identify a source for Docetaxel patient assistance information. Please reach out to our team if you feel that this is a mistake.
DOCETAXEL prescribing information can be found at the link below:
Information regarding DOCETAXEL’s side effects can be found at MedlinePlus